Boardroom Alpha
Boardroom Alpha
ECVT · Current Report (Form 8-K) · Filed June 30, 2026

Ecovyst Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 30, 2026
Period
Jun 30, 2026
Ticker
ECVT
Accession
0001193125-26-290479
Boardroom Alpha · Filing insights

Ecovyst adds a $100 million Incremental Term Loan to fund the INEOS Calabrian US/Canada acquisitions; closing completed for $190 million.

About Ecovyst Inc
Market cap
$1.1B
1Y TSR
+21.5%
3Y TSR
+1.9%
Board grade
C+
Sector
Basic Materials
CEO
Kurt Bitting
Last annual meeting: May 20, 2026 · View full Ecovyst Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2026

 

 

Ecovyst Inc.

 

 

Commission File Number: 001-38221

 

Delaware   81-3406833
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

600 Lee Road, Suite 200

Wayne, Pennsylvania

  19087
(Address of principal executive offices)   (Zip Code)

(484) 617-1200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
symbol

 

Name of each exchange
on which registered

Common stock, par value $0.01 per share   ECVT   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01

Entry into Material Definitive Agreement

On June 30, 2026 (the “Closing Date”), Ecovyst Catalyst Technologies LLC (the “Parent Borrower”), a wholly owned subsidiary of Ecovyst Inc., Eco Services Operations Corp. (“Eco Services”, and together with Parent Borrower, collectively, the “Borrowers”) and Ecovyst Midco II Inc. entered into the Fourth Amendment Agreement, dated as of the Closing Date (the “Fourth Amendment”), by and among the Borrowers, Ecovyst Midco II Inc., the other guarantors party thereto, the 2026 Incremental Term Lenders (as defined therein) and UBS AG, Stamford Branch, as administrative agent, which amended the Term Loan Credit Agreement, dated as of June 9, 2021 (as amended by the First Amendment Agreement, dated as of February 9, 2023, the Second Amendment Agreement, dated as of June 12, 2024, the Third Amendment Agreement, dated as of January 30, 2025, and as further amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Existing Credit Agreement”; and the Existing Credit Agreement, as amended by the Fourth Amendment, the “Credit Agreement”). All defined terms used in this Item 1.01 on Form 8-K that are not otherwise defined herein have the meanings ascribed to such terms in the Credit Agreement or Fourth Amendment, as applicable.

The Fourth Amendment provides for an additional $100.0 million first lien term loan (the “Incremental Term Loan”) as a fungible increase to the existing Initial Term Loans and makes certain other changes to the Existing Credit Agreement. The Incremental Term Loan will bear interest at the same variable rate as the Initial Term Loans, which is, at the option of the Borrowers, either Term SOFR plus 2.00% per annum or ABR plus 1.00% per annum. The amortization schedule, maturity date, collateral and other customary terms of the Incremental Term Loan are identical to those of the Initial Term Loans.

On the Closing Date, the Borrowers borrowed the Incremental Term Loan, the proceeds of which were used to finance the previously announced acquisition of the entire issued share capital of INEOS Calabrian Holdings Corp. (the “US Target”) and INEOS Calabrian Corporation Canada, Inc. (the “Canadian Target”), to pay fees and expenses in connection therewith and for general corporate purposes.

The foregoing description of the Fourth Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Fourth Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 2.03 by reference.

 

Item 8.01

Other Events

On June 30, 2026, Ecovyst Inc. (the “Company”), through its wholly owned subsidiaries New Structure Subco Inc. (the “US Purchaser”) and EV Industrial Chemical Subsidiary Holdings Inc. (the “Canadian Purchaser” and, together with the US Purchaser, the “Purchasers”), completed the previously announced acquisition of the entire issued share capital of the US Target and the Canadian Target pursuant to the Share Purchase Agreement (the “Purchase Agreement”), dated as of May 1, 2026, by and among INEOS Calabrian Holdings Limited, INEOS Calabrian Canada Holdings Limited, INEOS Enterprises Holdings Limited, the Company and the Purchasers, for a purchase price of $190 million, subject to certain customary adjustments specified therein, including for cash and working capital (the “Transaction”).

The foregoing description of the Transaction does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, a copy of which was filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 4, 2026, and the full text of which is incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 30, 2026   Ecovyst Inc.
    By:  

/s/ Michael Feehan

    Name:   Michael Feehan
    Title:   Vice President and Chief Financial Officer
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Ecovyst Inc (ECVT)

Reference

Frequently asked questions

When did Ecovyst Inc file this 8-K?
Ecovyst Inc (ECVT) filed this Current Report (Form 8-K) with the SEC on June 30, 2026. The accession number assigned by EDGAR is 0001193125-26-290479.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Ecovyst adds a $100 million Incremental Term Loan to fund the INEOS Calabrian US/Canada acquisitions; closing completed for $190 million. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Ecovyst Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Ecovyst Inc has filed under CIK 1708035, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer